Nimble Therapeutics is a biotechnology company dedicated to delivering on the promise of oral peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs. The Nimble platform combines massively parallel solid-phase synthesis, unrivaled chemical and structural diversity, sophisticated assays, and powerful machine learning and computational methods.
Company Details
- Employees
- 17
- Founded
- 2019
- Address
- 603 Science Dr, Madison,wisconsin 53711,united States
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nimbletherapeutics.com
- HQ
- Madison, Wisconsin
Nimble Therapeutics Questions
Nimble Therapeutics's website is nimbletherapeutics.com
Nimble Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nimble-therapeutics
Nimble Therapeutics has
17 employees.
View email and phone details for 17
employees at Nimble Therapeutics.
Nimble Therapeutics's industry is
Biotechnology Research
Nimble Therapeutics's top competitors are
Ladrx Corporation,
Newamsterdam Pharma Corporation,
Candel Therapeutics,
Chimerix, A Jazz Pharmaceuticals Company,
Biomarin Pharmaceutical Inc.,
Abbvie,
Citryll,
Elephas,
Invenra,
Editas Medicine.
Nimble Therapeutics's support email address is info@nimbletherapeutics.com
Nimble Therapeutics's categories are Biotechnology Research
Nimble Therapeutics's founding year is 2019
